📣 VC round data is live. Check it out!
- Public Comps
- Star Lake Bioscience
Star Lake Bioscience Valuation Multiples
Discover revenue and EBITDA valuation multiples for Star Lake Bioscience and similar public comparables like MBX Biosciences, KalVista Pharmaceuticals, GH Research, Bicara Therapeutics and more.
Star Lake Bioscience Overview
About Star Lake Bioscience
Star Lake Bioscience Co Inc is a China-based Pharmaceutical manufacturer. The company is mainly engaged in the research, development, production, and sales of chemical raw materials and pharmaceutical intermediates. Products offered by the company include proline, guanosine, adenosine, adenine, adefovir dipivoxil, memantine hydrochloride, Proline, threonine, lysine, among others. Its products are used in food processing, feed processing, and pharmaceutical manufacturing. Star Lake sells its products through direct sales and distributors in China and overseas markets.
Founded
1992
HQ

Employees
2.7K
Website
Financials (LTM)
EV
$2B
Valuation Multiples
Start free trialStar Lake Bioscience Financials
Star Lake Bioscience reported last 12-month revenue of $2B and EBITDA of $314M.
In the same LTM period, Star Lake Bioscience generated $389M in gross profit, $314M in EBITDA, and $147M in net income.
Revenue (LTM)
Star Lake Bioscience P&L
In the most recent fiscal year, Star Lake Bioscience reported revenue of $2B and EBITDA of $315M.
Star Lake Bioscience is profitable as of last fiscal year, with gross margin of 17%, EBITDA margin of 14%, and net margin of 6%.
Financial data powered by Morningstar, Inc.
Star Lake Bioscience Stock Performance
Star Lake Bioscience has current market cap of $1B, and enterprise value of $2B.
Market Cap Evolution
Star Lake Bioscience's stock price is $0.85.
Star Lake Bioscience share price increased by 0.1% in the last 30 days, and decreased by 21.1% in the last year.
Star Lake Bioscience has an EPS (earnings per share) of $0.09.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $1B | 0.0% | 0.1% | -24.3% | -21.1% | $0.09 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialStar Lake Bioscience Valuation Multiples
Star Lake Bioscience trades at 0.9x EV/Revenue multiple, and 6.9x EV/EBITDA.
EV / Revenue (LTM)
Star Lake Bioscience Financial Valuation Multiples
As of May 4, 2026, Star Lake Bioscience has market cap of $1B and EV of $2B.
Star Lake Bioscience has a P/E ratio of 9.6x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Star Lake Bioscience Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Star Lake Bioscience Margins & Growth Rates
Star Lake Bioscience grew revenue by 4% and EBITDA by 5% in the last fiscal year.
In the most recent fiscal year, Star Lake Bioscience reported gross margin of 17%, EBITDA margin of 14%, and net margin of 6%.
Star Lake Bioscience Margins
Star Lake Bioscience Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Star Lake Bioscience Operational KPIs
Star Lake Bioscience's revenue per employee in the last FY averaged $0.9M, while opex per employee averaged $0.1M for the same period.
Star Lake Bioscience's Rule of 40 is 18% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Star Lake Bioscience's Rule of X is 24% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Star Lake Bioscience Competitors
Star Lake Bioscience competitors include MBX Biosciences, KalVista Pharmaceuticals, GH Research, Bicara Therapeutics, WAVE Life Sciences, Liaoning Chengda Biotech, Immunocore Holdings, ArriVent BioPharma, HBM Holdings and Immatics.
Most Star Lake Bioscience public comparables operate across Biopharmaceuticals, BioTech and DeepTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| — | — | (10.7x) | (9.0x) | |||
| 25.8x | 12.3x | (7.3x) | — | |||
| — | — | (23.8x) | (16.6x) | |||
| — | — | (6.8x) | (6.3x) | |||
| 20.6x | 18.4x | (4.3x) | (4.2x) | |||
| 3.2x | 3.2x | 12.6x | 14.2x | |||
| 2.5x | 2.4x | (273.7x) | (24.5x) | |||
| — | — | (6.1x) | (6.0x) | |||
This data is available for Pro users. Sign up to see all Star Lake Bioscience competitors and their valuation data. Start Free Trial | ||||||
Star Lake Bioscience M&A Activity
Star Lake Bioscience has acquired 1 company to date.
Last acquisition by Star Lake Bioscience was on April 2nd 2022. Star Lake Bioscience acquired Ningxia Yipin for $759M (EV/Revenue multiple of ).
Latest Acquisitions by Star Lake Bioscience
| Description | Ningxia Yipin is a bio-fermentation technology company based in Ningxia, China, specializing in the production of L-lysine and other amino acids. Operating under Eppen brand, it supplies feed-grade additives to global livestock industries. The firm maintains production facilities in Shizuishan and holds certifications for high-purity fermentation processes. |
| HQ Country | |
| HQ City | Yinchuan |
| Deal Date | 2 Apr 2022 |
| Valuation | $759M |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Star Lake Bioscience acquisitions and their M&A valuation multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Star Lake Bioscience
| When was Star Lake Bioscience founded? | Star Lake Bioscience was founded in 1992. |
| Where is Star Lake Bioscience headquartered? | Star Lake Bioscience is headquartered in China. |
| How many employees does Star Lake Bioscience have? | As of today, Star Lake Bioscience has over 2K employees. |
| Is Star Lake Bioscience publicly listed? | Yes, Star Lake Bioscience is a public company listed on Shanghai Stock Exchange. |
| What is the stock symbol of Star Lake Bioscience? | Star Lake Bioscience trades under 600866 ticker. |
| When did Star Lake Bioscience go public? | Star Lake Bioscience went public in 1994. |
| Who are competitors of Star Lake Bioscience? | Star Lake Bioscience main competitors include MBX Biosciences, KalVista Pharmaceuticals, GH Research, Bicara Therapeutics, WAVE Life Sciences, Liaoning Chengda Biotech, Immunocore Holdings, ArriVent BioPharma, HBM Holdings, Immatics. |
| What is the current market cap of Star Lake Bioscience? | Star Lake Bioscience's current market cap is $1B. |
| What is the current revenue of Star Lake Bioscience? | Star Lake Bioscience's last 12 months revenue is $2B. |
| What is the current revenue growth of Star Lake Bioscience? | Star Lake Bioscience revenue growth (NTM/LTM) is 6%. |
| What is the current EV/Revenue multiple of Star Lake Bioscience? | Current revenue multiple of Star Lake Bioscience is 0.9x. |
| Is Star Lake Bioscience profitable? | Yes, Star Lake Bioscience is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Star Lake Bioscience? | Star Lake Bioscience's last 12 months EBITDA is $314M. |
| What is Star Lake Bioscience's EBITDA margin? | Star Lake Bioscience's last 12 months EBITDA margin is 13%. |
| What is the current EV/EBITDA multiple of Star Lake Bioscience? | Current EBITDA multiple of Star Lake Bioscience is 6.9x. |
| How many companies Star Lake Bioscience has acquired to date? | As of May 2026, Star Lake Bioscience has acquired 1 company. |
| What was the largest acquisition by Star Lake Bioscience? | $759M acquisition of Ningxia Yipin on 2nd April 2022 was the largest M&A Star Lake Bioscience has done to date. |
| What companies Star Lake Bioscience acquired? | Star Lake Bioscience acquired Ningxia Yipin. |
| In how many companies Star Lake Bioscience has invested to date? | Star Lake Bioscience hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Star Lake Bioscience
Lists including Star Lake Bioscience
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
